AAAAAA
Results: 1-25/29
Authors:
Coppes, MJ
Blanchette, VS
Citation: Mj. Coppes et Vs. Blanchette, Tribute to Dr. Maureen Andrew, J PED H ONC, 23(8), 2001, pp. 476-477
Authors:
Dockerwolcke, RM
Coppes, MJ
Citation: Rm. Dockerwolcke et Mj. Coppes, Adaptation of renal function after unilateral nephrectomy in children withrenal tumors, PED NEPHROL, 16(7), 2001, pp. 568-574
Authors:
Arceci, RJ
Coppes, MJ
Tubergen, DG
Citation: Rj. Arceci et al., Preface, HEMAT ONCOL, 15(4), 2001, pp. XI-XII
Authors:
Green, DM
Breslow, NE
Beckwith, JB
Ritchey, ML
Shamberger, RC
Haase, GM
D'Angio, GJ
Perlman, E
Donaldson, M
Grundy, PE
Weetman, R
Coppes, MJ
Malogolowkin, M
Shearer, P
Coccia, P
Kletzel, M
Thomas, PRM
Macklis, R
Tomlinson, G
Huff, V
Newbury, R
Weeks, D
Citation: Dm. Green et al., Treatment with nephrectomy only for small, stage I/favorable histology Wilms' tumor: A report from the National Wilms' Tumor Study Group, J CL ONCOL, 19(17), 2001, pp. 3719-3724
Authors:
Coppes-Zantinga, AR
Coppes, MJ
Pearn, J
Citation: Ar. Coppes-zantinga et al., Annals and chronicles - The Royal Children's Hospital in Brisbane, MED PED ONC, 37(3), 2001, pp. 157-158
Authors:
Russell, JA
Chaudhry, A
Booth, K
Brown, C
Woodman, RC
Valentine, K
Stewart, D
Ruether, JD
Ruether, BA
Jones, AR
Coppes, MJ
Bowen, T
Anderson, R
Bouchard, M
Rallison, L
Stotts, M
Poon, MC
Citation: Ja. Russell et al., Early outcomes after allogeneic stem cell transplantation for leukemia andmyelodysplasia without protective isolation: A 10-year experience, BIOL BLOOD, 6(2), 2000, pp. 109-114
Authors:
Coppes-Zantinga, AR
Coppes, MJ
Citation: Ar. Coppes-zantinga et Mj. Coppes, Sir James Paget (1814-1889): A Great Academic Victorian, J AM COLL S, 191(1), 2000, pp. 70-74
Authors:
Arcellana-Panlilio, MY
Egeler, AM
Ujack, E
Pinto, A
Demetrick, DJ
Robbins, SM
Coppes, MJ
Citation: My. Arcellana-panlilio et al., Decreased expression of the INK4 family of cyclin-dependent kinase inhibitors in Wilms tumor, GENE CHROM, 29(1), 2000, pp. 63-69
Authors:
Sandler, ES
Hagg, R
Coppes, MJ
Mustafa, MM
Gamis, A
Kamani, N
Wall, D
Citation: Es. Sandler et al., Hematopoietic stem cell transplantation (HSCT) with a conditioning regimenof busulfan, cyclophosphamide, and etoposide for children with acute myelogenous leukemia (AML): A phase I study of the Pediatric Blood and Marrow Transplant Consortium, MED PED ONC, 35(4), 2000, pp. 403-409
Authors:
Coppes, MJ
Ritchey, ML
Citation: Mj. Coppes et Ml. Ritchey, Managing nephroblastomatosis, MED PED ONC, 35(4), 2000, pp. 433-433
Authors:
Coppes-Zantinga, AR
Coppes, MJ
Citation: Ar. Coppes-zantinga et Mj. Coppes, Annals and chronicles - Pediatric oncology in Amsterdam, MED PED ONC, 35(3), 2000, pp. 159-162
Authors:
Coppes, MJ
Beckwith, JB
Citation: Mj. Coppes et Jb. Beckwith, Commentary - Clinical approach to renal lesions in children with multiple nephrogenic rests, MED PED ONC, 35(1), 2000, pp. 73-74
Authors:
Coppes-Zantinga, AR
Zucker, JM
Coppes, MJ
Citation: Ar. Coppes-zantinga et al., Odile Schweisguth, MD, Alma Mater of Pediatric Oncology - Silhouette, MED PED ONC, 34(1), 2000, pp. 59-60
Authors:
Coppes, MJ
Pritchard-Jones, K
Citation: Mj. Coppes et K. Pritchard-jones, Principles of Wilms' tumor biology, UROL CLIN N, 27(3), 2000, pp. 423
Authors:
Graham, GE
Graham, LM
Bridge, PJ
Maclaren, LD
Wolff, JEA
Coppes, MJ
Egeler, RM
Citation: Ge. Graham et al., Further evidence for genetic heterogeneity in familial hemophagocytic lymphohistiocytosis (FHLH), PEDIAT RES, 48(2), 2000, pp. 227-232
Authors:
Coppes, MJ
Yanofsky, R
Pritchard, S
Leclerc, JM
Howard, DR
Perrotta, M
Keays, S
Pyesmany, A
Dempsey, E
Pratt, CB
Citation: Mj. Coppes et al., Safety, tolerability, antiemetic efficacy, and pharmacokinetics of oral dolasetron mesylate in pediatric cancer patients receiving moderately to highly emetogenic chemotherapy, J PED H ONC, 21(4), 1999, pp. 274-283
Authors:
Coppes, MJ
Anderson, RA
Rallison, L
Truscott, R
Citation: Mj. Coppes et al., Southern Alberta Children's Cancer Program, PED HEM ONC, 16(6), 1999, pp. 501-507
Authors:
Coppes-Zantinga, AR
Coppes, MJ
Citation: Ar. Coppes-zantinga et Mj. Coppes, Past progressive - Max Wilms and "Die mischgeschwulste der niere", CAN MED A J, 160(8), 1999, pp. 1196-1196
Authors:
Russell, JA
Larratt, L
Brown, C
Turner, AR
Chaudhry, A
Booth, K
Woodman, RC
Wolff, J
Valentine, K
Stewart, D
Ruether, JD
Ruether, BA
Klassen, J
Jones, AR
Gyonyor, E
Egeler, M
Dunsmore, J
Desai, S
Coppes, MJ
Bowen, T
Anderson, R
Poon, MC
Citation: Ja. Russell et al., Allogeneic blood stem cell and bone marrow transplantation for acute myelogenous leukemia and myelodysplasia: influence of stem cell source on outcome, BONE MAR TR, 24(11), 1999, pp. 1177-1183
Authors:
Ross, JA
Coppes, MJ
Robison, LL
Citation: Ja. Ross et al., Population density and risk of childhood acute lymphoblastic leukaemia, LANCET, 354(9178), 1999, pp. 532-532
Authors:
Wolff, JEA
Sajedi, M
Coppes, MJ
Anderson, RA
Egeler, RM
Citation: Jea. Wolff et al., Radiation therapy and survival in choroid plexus carcinoma, LANCET, 353(9170), 1999, pp. 2126-2126
Authors:
Whitsett, SF
Kneppers, K
Coppes, MJ
Egeler, RM
Citation: Sf. Whitsett et al., Neuropsychologic deficits in children with Langerhans cell histiocytosis, MED PED ONC, 33(5), 1999, pp. 486-492
Authors:
Coppes-Zantinga, AR
Coppes, MJ
Citation: Ar. Coppes-zantinga et Mj. Coppes, Annals and chronicles - The children's hospitals in Montreal, MED PED ONC, 33(3), 1999, pp. III-V
Authors:
Coppes, MJ
Lau, R
Ingram, LC
Wiernikowski, JT
Grant, R
Howard, DR
Perrotta, M
Barr, R
Dempsey, E
Greenberg, ML
Leclerc, JM
Citation: Mj. Coppes et al., Open-label comparison of the antiemetic efficacy of single intravenous doses of dolasetron mesylate in pediatric cancer patients receiving moderatelyto highly emetogenic chemotherapy, MED PED ONC, 33(2), 1999, pp. 99-105
Authors:
Coppes-Zantinga, AR
Coppes, MJ
Citation: Ar. Coppes-zantinga et Mj. Coppes, Chronicle - The eponym "Wilms": A reminder of a surgeon's lifelong contributions to medicine, MED PED ONC, 32(6), 1999, pp. 438-439